Benchmark Investment Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,300
Closed -$463K 89
2022
Q4
$463K Hold
3,300
0.49% 59
2022
Q3
$424K Sell
3,300
-400
-11% -$57.7K 0.46% 61
2022
Q2
$522K Buy
3,700
+500
+16% +$71.4K 0.54% 59
2022
Q1
$445K Sell
3,200
-500
-14% -$76.6K 0.33% 77
2021
Q4
$645K Buy
+3,700
New +$617K 0.53% 54

Other funds holding CLX

Benchmark Investment Advisors's CLX Position: Q1 2023 in Review

Benchmark Investment Advisors sold out of Clorox (CLX) in Q1 2023, closing a stake of 3,300 shares — an estimated $463K sold.

Benchmark Investment Advisors first reported a position in CLX in Q4 2021 and held it in 5 quarters. The position peaked at $645K in Q4 2021. 1,140 funds tracked by Wall St. Rank hold CLX as of Q1 2023.

  • Benchmark Investment Advisors reported no remaining Clorox position as of Q1 2023 after selling out during the quarter.
  • Benchmark Investment Advisors sold 3,300 Clorox shares in Q1 2023, an estimated $463K.
  • Benchmark Investment Advisors first reported a position in Clorox in Q4 2021 and held it in 5 quarters.
  • Benchmark Investment Advisors's Clorox position peaked at $645K in Q4 2021.
  • 1,140 funds tracked by Wall St. Rank held Clorox as of Q1 2023.

Based on Benchmark Investment Advisors's 13F filing for Q1 2023, filed 15 May 2023.